Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study

BACKGROUND:Surgical site infection remains a complication of spine surgery despite routine use of prophylactic antibiotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical site infection after spine surgery. The purpose of the present st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and joint surgery. American volume 2014-01, Vol.96 (1), p.46-51
Hauptverfasser: Zebala, Lukas P, Chuntarapas, Tapanut, Kelly, Michael P, Talcott, Michael, Greco, Suellen, Riew, K Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 51
container_issue 1
container_start_page 46
container_title Journal of bone and joint surgery. American volume
container_volume 96
creator Zebala, Lukas P
Chuntarapas, Tapanut
Kelly, Michael P
Talcott, Michael
Greco, Suellen
Riew, K Daniel
description BACKGROUND:Surgical site infection remains a complication of spine surgery despite routine use of prophylactic antibiotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical site infection after spine surgery. The purpose of the present study was to assess the efficacy of intrawound vancomycin powder in terms of eradicating a known bacterial surgical site contamination in a rabbit spine surgery model. METHODS:Twenty New Zealand White rabbits underwent lumbar partial laminectomy and wire implantation. The surgical sites were inoculated, prior to closure, by injecting 100 μL of cefazolin-sensitive and vancomycin-sensitive Staphylococcus aureus (S. aureus) (1 × 10 colony-forming units [CFU]/mL) into the wound. Preoperative cefazolin was administered to all rabbits, and vancomycin powder (100 mg) was placed into the wound of ten rabbits prior to closure. The rabbits were killed on postoperative day four, and tissue and wire samples were obtained for bacteriologic assessment. An independent samples t test was used to assess mean group differences, and a Fisher exact test was used to assess differences in categorical variables. RESULTS:The vancomycin-treated and the control rabbits were similar in weight (mean [and standard deviation], 4.1 ± 0.5 kg and 4.0 ± 0.4 kg, respectively; p = 0.60) and sex distribution and had similar durations of surgery (21.7 ± 7.7 minutes and 16.9 ± 6.7 minutes; p = 0.15). The bacterial cultures of the surgical site tissues were negative for all ten vancomycin-treated rabbits and positive for all ten control rabbits (p < 0.0001). Bacterial growth occurred in thirty-nine of forty samples from the control group but in zero of forty samples from the vancomycin group (p < 0.0001). All blood and liver samples were sterile. No rabbit had evidence of sepsis or vancomycin toxicity. Gross examination of the surgical sites showed no differences between the groups. CONCLUSIONS:In a rabbit spine-infection model, intrawound vancomycin powder in combination with preoperative cefazolin eliminated S. aureus surgical site contamination. All rabbits that were managed with only prophylactic cefazolin had persistent S. aureus contamination. CLINICAL RELEVANCE:This animal study supports the findings in prior clinical reports that intrawound vancomycin powder helps reduce the risk of surgical site infections.
doi_str_mv 10.2106/JBJS.L.01257
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490751921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490751921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2938-2110294fc6052ebdc26f6e307a30c278466983555fd7ef8ead249169a6c7fb0b3</originalsourceid><addsrcrecordid>eNo9kN9P2zAQx61paC3d3nhGftwDKecfcZK9lQoYVSUQ3eAJWY7jrNkSG2yHqv_90hbQPdzp9LmvdB-ETghMKQFxvrhYrKbLKRCaZp_QmKQsTQjLxWc0BqAkKViajtBxCH8BgHPIvqAR5SynGeVj9HRjo1cb19sKPyirXbfVjcV3blMZjy-9qhqtogl41fs_w9jixz07dzaqrrEqNs7-wDOLh6uH5tXhe1WWTcSr2Ffbr-ioVm0w3976BP2-uvw1_5ksb69v5rNlomnB8oQSArTgtRaQUlNWmopaGAaZYqBplnMhinx4I62rzNS5URXlBRGFEjqrSyjZBH0_5D5799KbEGXXBG3aVlnj-iAJLyBLSUHJgJ4dUO1dCN7U8tk3nfJbSUDuhMqdULmUe6EDfvqW3JedqT7gd4MDwA_AxrXR-PCv7TfGy7VRbVxL2DkXlCUUCAcyVLJb5ew_yrZ_zw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490751921</pqid></control><display><type>article</type><title>Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Zebala, Lukas P ; Chuntarapas, Tapanut ; Kelly, Michael P ; Talcott, Michael ; Greco, Suellen ; Riew, K Daniel</creator><creatorcontrib>Zebala, Lukas P ; Chuntarapas, Tapanut ; Kelly, Michael P ; Talcott, Michael ; Greco, Suellen ; Riew, K Daniel</creatorcontrib><description>BACKGROUND:Surgical site infection remains a complication of spine surgery despite routine use of prophylactic antibiotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical site infection after spine surgery. The purpose of the present study was to assess the efficacy of intrawound vancomycin powder in terms of eradicating a known bacterial surgical site contamination in a rabbit spine surgery model. METHODS:Twenty New Zealand White rabbits underwent lumbar partial laminectomy and wire implantation. The surgical sites were inoculated, prior to closure, by injecting 100 μL of cefazolin-sensitive and vancomycin-sensitive Staphylococcus aureus (S. aureus) (1 × 10 colony-forming units [CFU]/mL) into the wound. Preoperative cefazolin was administered to all rabbits, and vancomycin powder (100 mg) was placed into the wound of ten rabbits prior to closure. The rabbits were killed on postoperative day four, and tissue and wire samples were obtained for bacteriologic assessment. An independent samples t test was used to assess mean group differences, and a Fisher exact test was used to assess differences in categorical variables. RESULTS:The vancomycin-treated and the control rabbits were similar in weight (mean [and standard deviation], 4.1 ± 0.5 kg and 4.0 ± 0.4 kg, respectively; p = 0.60) and sex distribution and had similar durations of surgery (21.7 ± 7.7 minutes and 16.9 ± 6.7 minutes; p = 0.15). The bacterial cultures of the surgical site tissues were negative for all ten vancomycin-treated rabbits and positive for all ten control rabbits (p &lt; 0.0001). Bacterial growth occurred in thirty-nine of forty samples from the control group but in zero of forty samples from the vancomycin group (p &lt; 0.0001). All blood and liver samples were sterile. No rabbit had evidence of sepsis or vancomycin toxicity. Gross examination of the surgical sites showed no differences between the groups. CONCLUSIONS:In a rabbit spine-infection model, intrawound vancomycin powder in combination with preoperative cefazolin eliminated S. aureus surgical site contamination. All rabbits that were managed with only prophylactic cefazolin had persistent S. aureus contamination. CLINICAL RELEVANCE:This animal study supports the findings in prior clinical reports that intrawound vancomycin powder helps reduce the risk of surgical site infections.</description><identifier>ISSN: 0021-9355</identifier><identifier>EISSN: 1535-1386</identifier><identifier>DOI: 10.2106/JBJS.L.01257</identifier><identifier>PMID: 24382724</identifier><language>eng</language><publisher>United States: Copyright by The Journal of Bone and Joint Surgery, Incorporated</publisher><subject>Animals ; Anti-Bacterial Agents - administration &amp; dosage ; Antibiotic Prophylaxis - methods ; Bacterial Load - drug effects ; Female ; Intraoperative Care ; Male ; Powders ; Rabbits ; Spine - surgery ; Staphylococcal Infections - prevention &amp; control ; Surgical Wound Infection - prevention &amp; control ; Vancomycin - administration &amp; dosage</subject><ispartof>Journal of bone and joint surgery. American volume, 2014-01, Vol.96 (1), p.46-51</ispartof><rights>Copyright 2014 by The Journal of Bone and Joint Surgery, Incorporated</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2938-2110294fc6052ebdc26f6e307a30c278466983555fd7ef8ead249169a6c7fb0b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24382724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zebala, Lukas P</creatorcontrib><creatorcontrib>Chuntarapas, Tapanut</creatorcontrib><creatorcontrib>Kelly, Michael P</creatorcontrib><creatorcontrib>Talcott, Michael</creatorcontrib><creatorcontrib>Greco, Suellen</creatorcontrib><creatorcontrib>Riew, K Daniel</creatorcontrib><title>Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study</title><title>Journal of bone and joint surgery. American volume</title><addtitle>J Bone Joint Surg Am</addtitle><description>BACKGROUND:Surgical site infection remains a complication of spine surgery despite routine use of prophylactic antibiotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical site infection after spine surgery. The purpose of the present study was to assess the efficacy of intrawound vancomycin powder in terms of eradicating a known bacterial surgical site contamination in a rabbit spine surgery model. METHODS:Twenty New Zealand White rabbits underwent lumbar partial laminectomy and wire implantation. The surgical sites were inoculated, prior to closure, by injecting 100 μL of cefazolin-sensitive and vancomycin-sensitive Staphylococcus aureus (S. aureus) (1 × 10 colony-forming units [CFU]/mL) into the wound. Preoperative cefazolin was administered to all rabbits, and vancomycin powder (100 mg) was placed into the wound of ten rabbits prior to closure. The rabbits were killed on postoperative day four, and tissue and wire samples were obtained for bacteriologic assessment. An independent samples t test was used to assess mean group differences, and a Fisher exact test was used to assess differences in categorical variables. RESULTS:The vancomycin-treated and the control rabbits were similar in weight (mean [and standard deviation], 4.1 ± 0.5 kg and 4.0 ± 0.4 kg, respectively; p = 0.60) and sex distribution and had similar durations of surgery (21.7 ± 7.7 minutes and 16.9 ± 6.7 minutes; p = 0.15). The bacterial cultures of the surgical site tissues were negative for all ten vancomycin-treated rabbits and positive for all ten control rabbits (p &lt; 0.0001). Bacterial growth occurred in thirty-nine of forty samples from the control group but in zero of forty samples from the vancomycin group (p &lt; 0.0001). All blood and liver samples were sterile. No rabbit had evidence of sepsis or vancomycin toxicity. Gross examination of the surgical sites showed no differences between the groups. CONCLUSIONS:In a rabbit spine-infection model, intrawound vancomycin powder in combination with preoperative cefazolin eliminated S. aureus surgical site contamination. All rabbits that were managed with only prophylactic cefazolin had persistent S. aureus contamination. CLINICAL RELEVANCE:This animal study supports the findings in prior clinical reports that intrawound vancomycin powder helps reduce the risk of surgical site infections.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Antibiotic Prophylaxis - methods</subject><subject>Bacterial Load - drug effects</subject><subject>Female</subject><subject>Intraoperative Care</subject><subject>Male</subject><subject>Powders</subject><subject>Rabbits</subject><subject>Spine - surgery</subject><subject>Staphylococcal Infections - prevention &amp; control</subject><subject>Surgical Wound Infection - prevention &amp; control</subject><subject>Vancomycin - administration &amp; dosage</subject><issn>0021-9355</issn><issn>1535-1386</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kN9P2zAQx61paC3d3nhGftwDKecfcZK9lQoYVSUQ3eAJWY7jrNkSG2yHqv_90hbQPdzp9LmvdB-ETghMKQFxvrhYrKbLKRCaZp_QmKQsTQjLxWc0BqAkKViajtBxCH8BgHPIvqAR5SynGeVj9HRjo1cb19sKPyirXbfVjcV3blMZjy-9qhqtogl41fs_w9jixz07dzaqrrEqNs7-wDOLh6uH5tXhe1WWTcSr2Ffbr-ioVm0w3976BP2-uvw1_5ksb69v5rNlomnB8oQSArTgtRaQUlNWmopaGAaZYqBplnMhinx4I62rzNS5URXlBRGFEjqrSyjZBH0_5D5799KbEGXXBG3aVlnj-iAJLyBLSUHJgJ4dUO1dCN7U8tk3nfJbSUDuhMqdULmUe6EDfvqW3JedqT7gd4MDwA_AxrXR-PCv7TfGy7VRbVxL2DkXlCUUCAcyVLJb5ew_yrZ_zw</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Zebala, Lukas P</creator><creator>Chuntarapas, Tapanut</creator><creator>Kelly, Michael P</creator><creator>Talcott, Michael</creator><creator>Greco, Suellen</creator><creator>Riew, K Daniel</creator><general>Copyright by The Journal of Bone and Joint Surgery, Incorporated</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140101</creationdate><title>Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study</title><author>Zebala, Lukas P ; Chuntarapas, Tapanut ; Kelly, Michael P ; Talcott, Michael ; Greco, Suellen ; Riew, K Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2938-2110294fc6052ebdc26f6e307a30c278466983555fd7ef8ead249169a6c7fb0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Antibiotic Prophylaxis - methods</topic><topic>Bacterial Load - drug effects</topic><topic>Female</topic><topic>Intraoperative Care</topic><topic>Male</topic><topic>Powders</topic><topic>Rabbits</topic><topic>Spine - surgery</topic><topic>Staphylococcal Infections - prevention &amp; control</topic><topic>Surgical Wound Infection - prevention &amp; control</topic><topic>Vancomycin - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zebala, Lukas P</creatorcontrib><creatorcontrib>Chuntarapas, Tapanut</creatorcontrib><creatorcontrib>Kelly, Michael P</creatorcontrib><creatorcontrib>Talcott, Michael</creatorcontrib><creatorcontrib>Greco, Suellen</creatorcontrib><creatorcontrib>Riew, K Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and joint surgery. American volume</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zebala, Lukas P</au><au>Chuntarapas, Tapanut</au><au>Kelly, Michael P</au><au>Talcott, Michael</au><au>Greco, Suellen</au><au>Riew, K Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study</atitle><jtitle>Journal of bone and joint surgery. American volume</jtitle><addtitle>J Bone Joint Surg Am</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>96</volume><issue>1</issue><spage>46</spage><epage>51</epage><pages>46-51</pages><issn>0021-9355</issn><eissn>1535-1386</eissn><abstract>BACKGROUND:Surgical site infection remains a complication of spine surgery despite routine use of prophylactic antibiotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical site infection after spine surgery. The purpose of the present study was to assess the efficacy of intrawound vancomycin powder in terms of eradicating a known bacterial surgical site contamination in a rabbit spine surgery model. METHODS:Twenty New Zealand White rabbits underwent lumbar partial laminectomy and wire implantation. The surgical sites were inoculated, prior to closure, by injecting 100 μL of cefazolin-sensitive and vancomycin-sensitive Staphylococcus aureus (S. aureus) (1 × 10 colony-forming units [CFU]/mL) into the wound. Preoperative cefazolin was administered to all rabbits, and vancomycin powder (100 mg) was placed into the wound of ten rabbits prior to closure. The rabbits were killed on postoperative day four, and tissue and wire samples were obtained for bacteriologic assessment. An independent samples t test was used to assess mean group differences, and a Fisher exact test was used to assess differences in categorical variables. RESULTS:The vancomycin-treated and the control rabbits were similar in weight (mean [and standard deviation], 4.1 ± 0.5 kg and 4.0 ± 0.4 kg, respectively; p = 0.60) and sex distribution and had similar durations of surgery (21.7 ± 7.7 minutes and 16.9 ± 6.7 minutes; p = 0.15). The bacterial cultures of the surgical site tissues were negative for all ten vancomycin-treated rabbits and positive for all ten control rabbits (p &lt; 0.0001). Bacterial growth occurred in thirty-nine of forty samples from the control group but in zero of forty samples from the vancomycin group (p &lt; 0.0001). All blood and liver samples were sterile. No rabbit had evidence of sepsis or vancomycin toxicity. Gross examination of the surgical sites showed no differences between the groups. CONCLUSIONS:In a rabbit spine-infection model, intrawound vancomycin powder in combination with preoperative cefazolin eliminated S. aureus surgical site contamination. All rabbits that were managed with only prophylactic cefazolin had persistent S. aureus contamination. CLINICAL RELEVANCE:This animal study supports the findings in prior clinical reports that intrawound vancomycin powder helps reduce the risk of surgical site infections.</abstract><cop>United States</cop><pub>Copyright by The Journal of Bone and Joint Surgery, Incorporated</pub><pmid>24382724</pmid><doi>10.2106/JBJS.L.01257</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9355
ispartof Journal of bone and joint surgery. American volume, 2014-01, Vol.96 (1), p.46-51
issn 0021-9355
1535-1386
language eng
recordid cdi_proquest_miscellaneous_1490751921
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Anti-Bacterial Agents - administration & dosage
Antibiotic Prophylaxis - methods
Bacterial Load - drug effects
Female
Intraoperative Care
Male
Powders
Rabbits
Spine - surgery
Staphylococcal Infections - prevention & control
Surgical Wound Infection - prevention & control
Vancomycin - administration & dosage
title Intrawound Vancomycin Powder Eradicates Surgical Wound Contamination: An in Vivo Rabbit Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T17%3A44%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrawound%20Vancomycin%20Powder%20Eradicates%20Surgical%20Wound%20Contamination:%20An%20in%20Vivo%20Rabbit%20Study&rft.jtitle=Journal%20of%20bone%20and%20joint%20surgery.%20American%20volume&rft.au=Zebala,%20Lukas%20P&rft.date=2014-01-01&rft.volume=96&rft.issue=1&rft.spage=46&rft.epage=51&rft.pages=46-51&rft.issn=0021-9355&rft.eissn=1535-1386&rft_id=info:doi/10.2106/JBJS.L.01257&rft_dat=%3Cproquest_cross%3E1490751921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490751921&rft_id=info:pmid/24382724&rfr_iscdi=true